CU Anschutz Medical Campus

Cardiology

Researchers identify new biomarker in quality of blood donations

A collaborative cohort of researchers, led by University of Colorado Anschutz Medical Campus professor Angelo D'Alessandro, has identified kynurenine as a critical new biomarker in the quality of stored red blood cells (RBCs), ...

Oncology & Cancer

CRISPR study lays groundwork for overcoming ovarian cancer

A team of researchers at the University of Colorado Anschutz Medical Campus has gained attention for their work on rethinking ovarian cancer disease progression and treatment. Equipped with highly advanced technology, they ...

Oncology & Cancer

The role of fibronectin in BRAF-mutant thyroid cancer treatment

New research overseen by University of Colorado Cancer Center member Rebecca Schweppe, Ph.D., could lead to improved treatment for people with thyroid cancer characterized by a mutation in the BRAF gene—a mutation also ...

page 2 from 40